A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR. (Q54275708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Christopher P Wardell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Gareth J Morgan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

M F Kaiser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S L Hockley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D B Begum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D Gonzalez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

F M Ross

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

F E Davies

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

15 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1754-1757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2013.12

22 February 2020

exact match

0 references

cites work

Molecular pathogenesis and a consequent classification of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

The genetic architecture of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

Prediction of cytogenetic abnormalities with gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.12

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2013.12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318961%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference